Trial Profile
Evaluation on Glycaemic Control and Weight Change of Once Daily Levemir (Insulin Detemir) in Type 2 Diabetes Mellitus Treated by an Intensive Insulin Treatment (ICT).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LEONCET2
- Sponsors Novo Nordisk
- 20 May 2009 Actual patient number (2289) added as reported by ClinicalTrials.gov.
- 20 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Oct 2008 Actual start date changed from Apr 2008 to Mar 2008 as reported by Clinicaltrials.gov.